Evan Newell, PhD

/content/dam/www/faculty-photos/N/evan-newell/evan-newell.jpg
Dr. Evan Newell PhD
faculty member

Evan Newell, PhD

Professor, Vaccine and Infectious Disease Division, Fred Hutch

Professor
Vaccine and Infectious Disease Division, Fred Hutch

Joint Professor, Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch

Joint Professor, Herbold Computational Biology Program
Public Health Sciences Division, Fred Hutch

Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch

Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch

Member, Pathogen-Associated Malignancies Integrated Research Center (PAM IRC), Fred Hutch

Member
Pathogen-Associated Malignancies Integrated Research Center (PAM IRC), Fred Hutch

Fax: 206.667.7711
Mail Stop: S2-204

Dr. Evan Newell is an immunologist who develops and employs new technologies for accurately identifying specific biological signatures of human health and disease, including cancer and infectious diseases. He and his team work with blood and tissue samples, using mass cytometry and other single-cell analysis methods to better understand how the specificities of immune T cells influence their roles in clinically productive responses against pathogens or cancers. 

Other Appointments & Affiliations

Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Member
Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Education

PhD Physiology, University of Toronto, Canada, 2006

BSc Immunology, McGill University, Canada, 2000

Research Interests

Human T cell immunology

Development and application of novel methods for identifying and characterizing antigen specific T cells in the context of cancer and chronic infection with the goal of identifying specific and accurate biomarkers of human health and disease based on antigen-specific T cells

Current Projects

Exploiting T cell antigen-specificity to gain clinically relevant insights about cancer and infectious disease

Development of novel methods for profiling antigen-specific T cell responses

Visualizing and comparing the high dimensional diversity of immune cells

"A lot of people here, like me, are working on T cells. We want to know exactly what they are recognizing on cancer cells and what they are doing differently in different people."

— Dr. Evan Newell

Find a Clinical Trial